Ponce Díaz-Reixa J, Sánchez Rodríguez-Losada J, Alvarez Castelo L, Romero Selas E, Fernández Rosado E, González Martin M
Servicio de Urología, Hospital Juan Canalejo, La Coruña.
Actas Urol Esp. 2007 Apr;31(4):366-71. doi: 10.1016/s0210-4806(07)73651-3.
VUR in spinal cord injured patients is cause of important morbidity and mortality. The aim of this paper is to make a statistical, retrospective and descriptive study to analyze VUR treatment results, in neurogenic bladder SCI patients.
We study 40 patients (80 renal units) with VUR in neurogenic bladders and SCI, between March, 1990 and November, 2004. Median age is 43.05 y (9-76). 77.5% of patients are males (3.4:1). Time from injury to VUR is 24.7m (0.2-87). Median follow up is 8.23a (0.5-29). Traumatic lesions are most frequent (70%). Median bladder capacity is 244.9 ml (43-555) and median bladder compliance is 16.12 ml/cm H2O (0.3-61.6). Detrusor overactivity is found in 72.2% and detrusor-sphincter dyssynergia in 71.8%. Initial conservative treatment is done with indwelling catheter and anticholinergics
Complete remission was found in 57.5% of RU, descending VUR a 23.7% (66.2% previously to 42.5% after; p<0.02), and predominant in unilateral reflux. Partial response was found in 3.8%, progression in 12.5% and recidiva post CR in 10.9%. Younger patients have better remission rates (39.4 to 47.6 y; p=0.04). Urodinamycs variables don't found any significant differences in treatment results. Endoscopic treatment with bulking agents gets a good response rate (56.3%) (p=0.18).
Initial conservative treatment gets a 23.7% reduction of VUR, especially in men, young and unilateral reflux patients. Anyhow, we observe some progression and recidiva. Detrusor overactivity and detrusor-sphincter dyssynergia didn't influence in treatment results, but they are found in all patients with recidiva. With longer reflux evolution, we observe better responses, but also a higher recidiva rate (p=0.007). Endoscopic bulky injection techniques found out a good response rate (56.3%), also in patients with recidiva after conservative treatment.
脊髓损伤患者的膀胱输尿管反流是重要的发病和死亡原因。本文旨在进行一项统计性、回顾性和描述性研究,以分析神经源性膀胱脊髓损伤患者的膀胱输尿管反流治疗结果。
我们研究了1990年3月至2004年11月期间40例患有神经源性膀胱和脊髓损伤且伴有膀胱输尿管反流的患者(80个肾单位)。中位年龄为43.05岁(9 - 76岁)。77.5%的患者为男性(男女比例为3.4:1)。从损伤到出现膀胱输尿管反流的时间为24.7个月(0.2 - 87个月)。中位随访时间为8.23年(0.5 - 29年)。创伤性损伤最为常见(70%)。中位膀胱容量为244.9毫升(43 - 555毫升),中位膀胱顺应性为16.12毫升/厘米水柱(0.3 - 61.6毫升/厘米水柱)。72.2%的患者存在逼尿肌过度活动,71.8%的患者存在逼尿肌-括约肌协同失调。初始保守治疗采用留置导尿管和抗胆碱能药物。
57.5%的肾单位完全缓解,下行性膀胱输尿管反流占23.7%(之前为66.2%,之后为42.5%;p<0.02),且主要为单侧反流。部分缓解为3.8%,进展为12.5%,完全缓解后复发为10.9%。年轻患者的缓解率更高(39.4至47.6岁;p = 0.04)。尿动力学变量在治疗结果中未发现任何显著差异。使用填充剂的内镜治疗获得了良好的有效率(56.3%)(p = 0.18)。
初始保守治疗使膀胱输尿管反流减少了23.7%,尤其在男性、年轻和单侧反流患者中。无论如何,我们观察到了一些进展和复发情况。逼尿肌过度活动和逼尿肌-括约肌协同失调对治疗结果没有影响,但在所有复发患者中均有发现。随着反流病程延长,我们观察到更好的反应,但复发率也更高(p = 0.007)。内镜下大容量注射技术也获得了良好的有效率(56.3%),对于保守治疗后复发的患者也是如此。